DoW Bone Marrow Failure, Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 17, 2026
- Amount
- Program total $4M
- Closes
- Nov 4, 2026 (in 49 days)
Similar opportunities open now
- DoW Bone Marrow Failure, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Bone Marrow Failure, Resource Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Duchenne Muscular Dystrophy, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 12 days
Classification and identifiers
- Solicitation number
- HT942526BMFRPIDA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4M
Who can apply
About this opportunity
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. Distinctive Features: This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI. Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.